Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
2
50%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Other(4)

Detailed Status

unknown4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 12 (50.0%)
Phase 42 (50.0%)

Trials by Status

unknown4100%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_4

A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis

NCT03932006
unknownphase_1

Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency

NCT02456688
unknownphase_1

A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers

NCT02426060
unknownphase_4

A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis

NCT01985165

Clinical Trials (4)

Showing 4 of 4 trials
NCT03932006Phase 4

A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis

Unknown
NCT02456688Phase 1

Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency

Unknown
NCT02426060Phase 1

A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers

Unknown
NCT01985165Phase 4

A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4